Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Rexahn Pharmaceuticals Inc.
()
Rexahn Pharmaceuticals Completes Stage 1 and Begins Enrollment in Stage 2 of Archexin® Phase IIa Clinical Trial in Metastatic Renal Cell Carcinoma (2/8/2016)
view
Nobilis Health Corp.
()
Hagens Berman Reminds Nobilis Health Corp. (NYSEMKT: HLTH) Investors of March 21, 2016 Lead Plaintiff Deadline in a Class Action Lawsuit (2/8/2016)
view
Biota Pharmaceuticals
(NASDAQ: AVIR)
Biota Commences Dosing in Phase 2 Trial of Antiviral Therapy BTA074 for Topical Treatment of Condyloma (2/8/2016)
view
Celgene Corp.
(CELG:NASDAQ)
ImmunoGen/Merck Collaborate for Ovarian Cancer Study (2/5/2016)
view